Presentation is loading. Please wait.

Presentation is loading. Please wait.

Crizotinib-resistant NPM-ALK mutants retain sensitivity to ganetespib.

Published byBarnard Norton Modified over 5 years ago

Similar presentations

Presentation on theme: "Crizotinib-resistant NPM-ALK mutants retain sensitivity to ganetespib."— Presentation transcript:

1 Crizotinib-resistant NPM-ALK mutants retain sensitivity to ganetespib.
Crizotinib-resistant NPM-ALK mutants retain sensitivity to ganetespib. A, ganetespib and crizotinib sensitivity was assessed in crizotinib-sensitive NPM-ALK BaF3 cells and crizotinib-resistant NMP-ALK mutants. Relative IC50 values are plotted on the basis of the sensitivity of the parental NPM-ALK BaF3 line to each compound. Clinically relevant mutations in NSCLC are indicated by asterisks. B, dose–response analysis of ganetespib. Crizotinib-sensitive NPM-ALK/BaF3 cells (top left) together with NPM-ALK/BaF3 containing the indicated amino acid substitutions known to confer crizotinib resistance were incubated for 24 hours, with the range of ganetespib concentrations indicated, and the stability of the NPM-ALK protein expressed in each line was assessed by immunoblotting. C, kinetics of ganetespib-associated NPM-ALK protein degradation. The NPM-ALK protein degradation response of crizotinib-sensitive NPM-ALK/BaF3 and NPM-ALK/BaF3 containing the L1196M gatekeeper mutation to incubation in 250 nmol/L ganetespib for the indicated times is shown. Jim Sang et al. Cancer Discovery 2013;3: ©2013 by American Association for Cancer Research

Download ppt "Crizotinib-resistant NPM-ALK mutants retain sensitivity to ganetespib."

Similar presentations

Enhanced DNA damage in IDH1 mutant glioma cells.

Enhanced DNA damage in IDH1 mutant glioma cells.
Inhibition of FGFR fusion kinase activity repressed tumor growth in a mouse xenograft model. Inhibition of FGFR fusion kinase activity repressed tumor.

Inhibition of FGFR fusion kinase activity repressed tumor growth in a mouse xenograft model. Inhibition of FGFR fusion kinase activity repressed tumor.
IDH1 mutant glioma cells are sensitive to TMZ

IDH1 mutant glioma cells are sensitive to TMZ
Clonal evolution of resistance to sequential ALK inhibitor therapy.

Clonal evolution of resistance to sequential ALK inhibitor therapy.
SCLCs and LCNECs are sensitive to PARP inhibition in vitro.

SCLCs and LCNECs are sensitive to PARP inhibition in vitro.
NF1 silencing confers resistance of PC9 lung adenocarcinoma cells to erlotinib (erl). NF1 silencing confers resistance of PC9 lung adenocarcinoma cells.

NF1 silencing confers resistance of PC9 lung adenocarcinoma cells to erlotinib (erl). NF1 silencing confers resistance of PC9 lung adenocarcinoma cells.
Combined inhibition of MAP kinase and KIT signaling destabilizes ETV1 protein and results in enhanced growth suppression of human GIST cells. Combined.

Combined inhibition of MAP kinase and KIT signaling destabilizes ETV1 protein and results in enhanced growth suppression of human GIST cells. Combined.
Fig. 4. Functional annotation of VUS in EGFR.

Fig. 4. Functional annotation of VUS in EGFR.
AKT dependence of ovarian cancer cell lines.

AKT dependence of ovarian cancer cell lines.
NF1 downregulation activates MAPK pathway signaling.

NF1 downregulation activates MAPK pathway signaling.
The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma cells. The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma.

The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma cells. The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma.
A, left: indicated MEFs were transfected as described in the Methods section. A, left: indicated MEFs were transfected as described in the Methods section.

A, left: indicated MEFs were transfected as described in the Methods section. A, left: indicated MEFs were transfected as described in the Methods section.
KIF1Bβ promotes DHX9 nuclear localization.

KIF1Bβ promotes DHX9 nuclear localization.
Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer  Soyeon Kim, PhD, Tae Min Kim, MD, PhD,

Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer  Soyeon Kim, PhD, Tae Min Kim, MD, PhD,
Fig. 3. TKI sensitivity assessed by the MANO method.

Fig. 3. TKI sensitivity assessed by the MANO method.
A and B, CO-1686–resistant NCI-H1975 cell clones, COR1-1 and COR10-1 display a reduced dependence on EGFR signaling for survival. A and B, CO-1686–resistant.

A and B, CO-1686–resistant NCI-H1975 cell clones, COR1-1 and COR10-1 display a reduced dependence on EGFR signaling for survival. A and B, CO-1686–resistant.
The role of SRC-C3G-RAP1 signaling in transformation induced by CRKL

The role of SRC-C3G-RAP1 signaling in transformation induced by CRKL
mTORC1- and mTORC2-activating mutations in MTOR and RHEB

mTORC1- and mTORC2-activating mutations in MTOR and RHEB
Fig. 6. Effect of SAHA and ML-60218 on histone acetylation, BAX, and p21CDKN1A expression.PANC-1 and BxPC-3 cells were incubated for 48 hours with 5 µM.

Fig. 6. Effect of SAHA and ML on histone acetylation, BAX, and p21CDKN1A expression.PANC-1 and BxPC-3 cells were incubated for 48 hours with 5 µM.
MMAE resistance and intracellular accumulation.

MMAE resistance and intracellular accumulation.

Similar presentations

Ads by Google